DISSECTION 2.0

Whether pelvic lymph node dissection offers an oncological benefit remains unknown. This study will compare extended pelvic lymph node dissection versus no dissection in PSMA PET-negative, T3, or Grade Group > 2 prostate cancer patients. The study will be conducted across all major urological clinics in Switzerland (KFS-5775-02-2023).